Related references
Note: Only part of the references are listed.Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Antiphospholipid syndrome
Guillermo Ruiz-Irastorza et al.
LANCET (2010)
Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice
R. A. S. Roubey
LUPUS (2010)
Statins for the Treatment of Antiphospholipid Syndrome?
Praveen Jajoria et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
A. Ruffatti et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
R. Kaiser et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
How we diagnose the antiphospholipid syndrome
Bill Giannakopoulos et al.
BLOOD (2009)
Classification of Stroke Subtypes
P. Amarenco et al.
CEREBROVASCULAR DISEASES (2009)
Determinants of Risk for Venous and Arterial Thrombosis in Primary Antiphospholipid Syndrome and in Antiphospholipid Syndrome with Systemic Lupus Erythematosus
Adriana Danowski et al.
JOURNAL OF RHEUMATOLOGY (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
Rolf T. Urbanus et al.
LANCET NEUROLOGY (2009)
Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort
B. E. Tan et al.
LUPUS (2009)
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Robert J. Glynn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events The PICSS-APASS Study
Kumar Rajamani et al.
STROKE (2009)
Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry
Vanessa Roldan et al.
THROMBOSIS RESEARCH (2009)
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism
Madeleine Verhovsek et al.
ANNALS OF INTERNAL MEDICINE (2008)
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
Sergio Siragusa et al.
BLOOD (2008)
Grades of recommendation for antithrombotic agents
Gordon H. Guyatt et al.
CHEST (2008)
Antithrombotic and thrombolytic therapy for ischemic stroke
Gregory W. Albers et al.
CHEST (2008)
Hemorrhagic complications of anticoagulant and thrombolytic treatment
Sam Schulman et al.
CHEST (2008)
Antithrombotic therapy for venous thromboembolic disease
Clive Kearon et al.
CHEST (2008)
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients
T. Hereng et al.
LUPUS (2008)
Anticoagulation treatment withdrawal in primary antiphospholipid syndrome when anticardiolipin antibodies become negative
J. Criado-Garcia et al.
REVISTA CLINICA ESPANOLA (2008)
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
Guillermo Ruiz-Irastorza et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
A computerized algorithm for etiologic classification of ischemic stroke - The causative classification of stroke system
Hakan Ay et al.
STROKE (2007)
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Monica Galli et al.
BLOOD (2007)
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome - A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
Doruk Erkan et al.
ARTHRITIS AND RHEUMATISM (2007)
Current concepts on the pathogenesis of the antiphospholipid syndrome
Bill Giannakopoulos et al.
BLOOD (2007)
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients
T. Tarr et al.
LUPUS (2007)
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus
Agustin Martincz-Berriotxoa et al.
LUPUS (2007)
Factors related to the risk of thrombosis in patients with lupus antiphospholipid antibodies and
Fernando Martinez et al.
MEDICINA CLINICA (2006)
Management of antiphospholipid antibody syndrome - A systematic review
W Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Incidence and risk factors of thromboembolism in systemic lupus erythematosus - A comparison of three ethnic groups
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2005)
Recurrent miscarriage and long-term thrombosis risk: a case-control study
S Quenby et al.
HUMAN REPRODUCTION (2005)
Dermatologic manifestations of the antiphospholipid syndrome -: Two hundred consecutive cases
C Francès et al.
ARTHRITIS AND RHEUMATISM (2005)
A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis
R Forastiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS)
G Finazzi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy
F Dentali et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus
G Ruiz-Irastorza et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
MPJ van Goor et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
M Galli et al.
BLOOD (2003)
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
MA Crowther et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report
M Lockshin et al.
LUPUS (2003)
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
D Erkan et al.
RHEUMATOLOGY (2002)
Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera et al.
ARTHRITIS AND RHEUMATISM (2002)
Diagnostic testing for coagulopathies in patients with ischemic stroke
CD Bushnell et al.
STROKE (2000)
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome
MG Tektonidou et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2000)
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies -: Do the benefits outweigh the risks?: A decision analysis
DG Wahl et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
